Variables | Inappropriate high dose Frequency (%) | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|---|
OR (95%CI) | p-value | OR (95%CI) | p-value | ||
Gender | Â | Â | Â | Â | Â |
Male | 96 (56.1) | Referent | Â | Â | Â |
Female | 66 (50.1) | 0.78 (0.49–1.23) | 0.288 | - | - |
Age (years) | Â | Â | Â | Â | Â |
≤ 40 | 9 (14.3) | Referent |  |  |  |
41–60 | 105 (61.4) | 9.54 (4.42–20.61) | < 0.001 | 5.76 (2.46–13.50) | < 0.001 |
> 60 | 48 (69.6) | 13.71 (5.73–32.81) | < 0.001 | 9.49 (2.87–21.56) | < 0.001 |
Weight (kilogram) | Â | Â | Â | Â | Â |
41–60 | 6 (22.2) | Referent |  |  |  |
61–80 | 60 (55.6) | 4.37 (1.64–11.70) | 0.003 | 2.75 (0.84–8.93) | 0.093 |
> 80 | 96 (57.1) | 4.67 (1.79–12.16) | 0.002 | 2.82 (0.87–9.12) | 0.083 |
CKD stage | Â | Â | Â | Â | Â |
3 | 6 (40.0) | Referent | Â | Â | Â |
4 | 45 (42.9) | 1.12 (0.37–3.39) | 0.834 | 0.37 (0.07–1.89) | 0.230 |
5 | 111 (60.7) | 2.31 (0.79–6.77) | 0.126 | 1.24 (0.26–5.96) | 0.790 |
Hypertension | Â | Â | Â | Â | Â |
No | 18 (37.5) | Referent | Â | Â | Â |
Yes | 144 (56.5) | 2.16 (1.15–4.08) | 0.017 | 2.68 (1.24–5.80) | 0.012 |
Anemia | Â | Â | Â | Â | Â |
No | 24 (36.4) | Referent | Â | Â | Â |
Yes | 138 (58.2) | 2.44 (1.39–4.29) | 0.002 | 1.90 (0.95–3.78) | 0.067 |
Diabetes mellitus | Â | Â | Â | Â | Â |
No | 63 (36.8) | Referent | Â | Â | Â |
Yes | 99 (75.0) | 5.14 (3.11–8.49) | < 0.001 | 3.47 (1.91–6.32) | < 0.001 |
Cardiovascular disease | Â | Â | Â | Â | Â |
No | 108 (48.0) | Referent | Â | Â | Â |
Yes | 54 (96.2) | 2.44 (1.41–4.21) | 0.001 | 2.82 (1.40–5.67) | 0.004 |
Other comorbidities | Â | Â | Â | Â | Â |
No | 156(54.2) | Referent | Â | Â | Â |
Yes | 6 (40.0) | 0.56 (0.20–1.63) | 0.289 | - | - |